GW Pharmaceuticals

Analyzing GW Pharmaceuticals’ Q4 Earnings and Outlook

On Tuesday, GW Pharmaceuticals reported its fourth-quarter earnings after the market closed. For the quarter, the company reported revenue of $109.1 million.

Why Did Cowen Downgrade Aurora Cannabis?

On Monday, MarketWatch reported that Cowen downgraded Aurora Cannabis from "outperform" to "market perform" and lowered the target price.
acreage holdings

Will Acreage Holdings’ Q4 Results Help Its Stock?

Acreage Holdings will report its fourth-quarter and fiscal 2019 results today after the market closes. Analysts expect the company to report revenue growth.

Ohio Wants to Legalize Recreational Marijuana

Since medical marijuana has boomed in Ohio, the state wants to enjoy recreational cannabis as well. Notably, Ohio legalized medical marijuana in 2016.
Green Growth

Green Growth Brands Reported Mixed Q2 Performance

On Monday, Green Growth Brands reported its earnings results for the second quarter of fiscal 2020. The company reported revenues of $21.1 million.

HEXO Stock Fell after a Downgrade from Jefferies

On February 21, HEXO fell to a low of 1.40 Canadian dollars and closed at 1.41 Canadian dollars. The stock fell 2.1% from the previous day's closing price.

Elizabeth Warren Unveils Plan for Marijuana Legalization

According to Warren's new marijuana plan, the federal legalization process would start within 100 days of her taking office.
Cronos Group

What to Expect from Cronos Group’s Q4 Earnings

Cronos Group will report its fourth-quarter earnings before the market opens on Thursday. Analysts expect double-digit revenue growth sequentially.

Will MedMen Deliver Any Good News in Its Q2 Earnings?

MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.